alkyneÀazide cycloadditions can take place under mild
conditions in the absence of copper thanks to favorable
entropy effects on the corresponding transition states.9
different strategies: deprotonation of phenylglycidol fol-
lowed by substitution on the corresponding propargyl
halide (Scheme 2, route A) or attack of a propargyl alkoxide
to the tosylate ester of phenylglycidol (Scheme 2, route B).
Scheme 1. Aims of the Present Work
Scheme 2. Preparation of Phenyglycidyl Propargyl Ethers 1aÀg
Herein, we report that enantiopure compounds invol-
ving triazole rings fused to seven-membered heterocycles
(oxepanes, thiepanes, and azepanes) can be easily obtained
from the corresponding propargyl derivatives (ethers,
thioethers, and amines) of phenylglycidol in a two-step,
one-pot operation, which is not mediated by any metallic
source (Scheme 1). Despite the potential interest of these
heterocyclic systems in medicinal chemistry,10 arising from
its close structural similarity with benzodiazepine drugs
such as Triazolam, Alprazolam (Trankimazin, Xanax),
and Estazolam (Figure 1), synthetic methods for their
preparation are scarce,9c,f,10b,11 and all chiral approaches
to these compounds rely on the construction of the mole-
cules on carbohydrate educts.12
The results obtained in the preparation of these ethers
are summarized in Table 1.
Table 1. Preparation of Phenyglycidyl Propargyl Ethers 1aÀg
entry
R
method
yield [%]
product
1
2
3
4
5
6
7
H
A
A
A
A
A
B
Ba
86
80
78
80
85
53
74
1a
1b
1c
1d
1e
1f
Me
Ph
2-naphthyl
n-pent
CH2OPMB
CH2OH
1g
a Obtained by deprotection of 1f with DDQ.
With ethers 1aÀg in hand, the stage was set to search for
the optimal reaction conditions for the planned cascade
process, which was carried out with 1a as the model
substrate. At this point, it is worth mentioning that since
the very beginning it became apparent that the kinetics
governing the two consecutive reactions rendered isolation
of the intermediate azido alcohol 2a a hopeless task. Thus,
no reaction conditions could be found where 2a could be
formed without concomitant generation of significant
amounts of the cyclization product 3a.13 Nevertheless, this
only played to our advantage, since fine-tuning of reaction
conditions for the two consecutive processes would allow
the transformation to be carried out in a one-pot manner,
thus avoiding the isolation of potentially dangerous
organic azides.
Figure 1. Benzodiazepine drugs involving triazole substructures.
For the preparation of oxepane-type products, propar-
gyl ethers of phenylglycidol (1aÀg) were prepared by two
(9) (a) Oliva, A. I.; Christmann, U.; Font, D.; Cuevas, F.; Ballester,
ꢀ
P.; Buschmann, H.; Torrens, A.; Yenes, S.; Pericas, M. A. Org. Lett.
2008, 10, 1617. (b) Balducci, E.; Belluci, L.; Petricci, E.; Taddei, M.; Tafi,
A. J. Org. Chem. 2009, 74, 1314. (c) Declerck, V.; Toupet, L.; Martinez,
J.; Lamaty, F. J. Org. Chem. 2009, 74, 2004. (d) Chowdhury, C.;
Mukherjee, S.; Das, B.; Achari, B. J. Org. Chem. 2009, 74, 3612. (e)
Li, R.; Jansen, D. J.; Datta, A. Org. Biomol. Chem. 2009, 7, 1921. (f)
Brawn, R. A.; Welzel, M.; Lowe, J. T.; Panek, J. S. Org. Lett. 2010, 12,
336.
(10) (a) Hein, C. D.; Liu, X. M.; Wang, D. Pharm. Res. 2008, 25,
2216. (b) Donald, J. R.; Martin, S. F. Org. Lett. 2011, 13, 852.
(11) (a) Padwa, A.; Ku, A.; Ku, H.; Mazzu, A. J. Org. Chem. 1978, 43,
66. (b) Orlek, B. S.; Sammes, P. G.; Weller, D. J. Tetrahedron 1993, 49,
8179. (c) Orlek, B. S.; Sammes, P. G.; Weller, D. J. J. Chem. Soc., Chem.
Commun. 1993, 607. (d) Garanti, L.; Molteni, G.; Zecchi, G. Heterocycles
1994, 38, 291. (e) Alajarın, M.; Cabrera, J.; Pastor, A.; Villalgordo, J. M.
Tetrahedron Lett. 2007, 48, 3495.
The first efforts toward optimization focused on the
solvent. Here, the choice was quite narrow since we wanted
(12) (a) Tripathi, S.; Singha, K.; Achari, B.; Mandal, S. Tetrahedron
2004, 60, 4959. (b) Hotha, S.; Anegundi, R. I.; Natu, A. A. Tetrahedron
Lett. 2005, 46, 4585. (c) Chandrasekhar, S.; Rao, C. L.; Nagesh, C.; Reddy,
C. R.; Sridhar, B. Tetrahedron Lett. 2007, 48, 5869. (d) Anegundi, R. I.;
Puranik, V. G.; Hotha, S. Org. Biomol. Chem. 2008, 6, 779. (e) Jarosz, S.;
Lewandowski, B.; Listkowski, A. Synthesis 2008, 913.
(13) Throughout the rest of the work no intermediates were isolated
other than 2a. For the complete characterization of 2a, see Supporting
Information.
Org. Lett., Vol. 13, No. 19, 2011
5045